Loading clinical trials...

Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365) | Clinical Trials | Clareo Health

COMPLETEDPHASE4

Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)

Quality of Life in Asthma and Rhinitis Allergic With Singulair

NCT00380705•Organon and Co

View on ClinicalTrials.gov

Summary

Allow physicians not familiar with anti-leukotriene based therapy to test it

Eligibility

Age

6 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Establish diagnosis of mild to moderate chronic asthma and/or allergic rhinitis currently on treatment
•Voluntary acceptance to participate in the study

Exclusion Criteria

•Patients with cystic fibrosis
•Patients with known hypersensitivity to singulair or any of its components
•Patients with severe chronic asthma

Key Dates

Start Date

March 18, 2005

Primary Completion Date

July 29, 2005

Completion Date

July 29, 2005

Last Updated

August 15, 2024

Enrollment

ESTIMATED participants

Conditions

AsthmaRhinitis Allergic

Interventions

MK0476, Singulair, montelukast sodium / Duration of Treatment: 8 Weeks

DRUG

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)

NCT02327897

Asthma

View study

RECRUITINGPHASE2

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

NCT07219173

Asthma

View study

RECRUITINGNA

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

NCT07486401

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 15, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)

Inclusion Criteria

Exclusion Criteria

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma

To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong

A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma